semaglutide alcoholism Once-weekly versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial Semaglutide and Alcohol - Do

Modification of Diet in Renal Disease Study Group

If you're in the Plano, Frisco, Allen, McKinney, or Dallas area and struggling with digestive issues related to GLP-1 medications, I'm here to help

Proton pump inhibitors may benefit patients with reflux symptoms, though they do not address the underlying motility issue

Gradual Dose Reduction: The Evidence-Based Approach Rather than stopping abruptly, a stepped dose reduction over 812 weeks allows your appetite-regulation system to recalibrate gradually

The aims of these trials is to achieve fat-selective weight loss, improved body composition and end-organ protection via a triple mechanism effect in people living with obesity [114]

Weight loss and triglyceride reduction create a positive feedback loop